ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology - TMX Newsfile

A company licensed AI technology to help identify people at risk of liver disease earlier. This could improve disease detection, though it is one company's announcement rather than a widespread shift.